Evidence map›Paper›PMID 40345430›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2025

In-hospital mortality among children and adults hospitalized with COVID-19 in Africa across pre-delta, delta, and omicron SARS-CoV-2 waves.

Seth Inzaule, Ronaldo Silva, Soe Soe Thwin, Jassat Waasila, Alimuddin Zumla, Jamie Rylance, John Appiah, Janet Diaz, Silvia Bertagnolio

Abstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Seth InzauleWorld Health Organization, Geneva, Switzerland.
Ronaldo SilvaWorld Health Organization, Geneva, Switzerland.
Soe Soe ThwinWorld Health Organization, Geneva, Switzerland.
Jassat WaasilaNational Institute for Communicable Diseases, Johannesburg, South Africa.
Alimuddin ZumlaDivision of Infection and Immunity, Center for Clinical Microbiology, University College London; and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK.
Jamie RylanceWorld Health Organization, Geneva, Switzerland.
John AppiahWorld Health Organization, Geneva, Switzerland.
Janet DiazWorld Health Organization, Geneva, Switzerland.
Silvia BertagnolioWorld Health Organization, Geneva, Switzerland,. Electronic address: bertagnolios@who.int.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundThis study examines in-hospital mortality among children and adults hospitalized with COVID-19 across the pre-Delta, Delta, and Omicron waves in the African region.

methodWe conducted a retrospective cohort study using individual-level data from 520,810 hospitalized children and adults in 13 African countries. Cox proportional hazards regression models were used to assess the impact of SARS-CoV-2 variants on in-hospital mortality.

findingsAmong children, the risk of in-hospital mortality was comparable between pre-Delta and Delta waves (aHR 1.02, 95% CI 0.77-1.35). In adults, mortality increased by 6% during Delta wave compared with pre-Delta wave (aHR 1.06, 95% CI 1.04-1.09). During Omicron wave, mortality risk decreased significantly by 42% in children (aHR 0.58, 95% CI 0.43-0.80) and 59% in adults (aHR 0.41, 95% CI 0.40-0.43) compared to the Delta wave. Notably, the reduction in mortality risk during the Omicron wave was less pronounced for children with severe or critical COVID-19, those co-infected with HIV, and adults co-infected with either HIV or tuberculosis.

conclusionDespite a general reduction in mortality risk during Omicron wave, persistently high mortality in specific high-risk groups underscores the importance of prioritizing booster vaccinations and intensified treatment for vulnerable populations as per WHO recommendations.

Indexed as

COVID-19Hospital MortalitySARS-CoV-2AdolescentAdultAfricaAgedChildChild, PreschoolFemaleHospitalizationHumansInfantMaleMiddle AgedRetrospective StudiesAfrican regionChildren and adultsCOVID-19SARS-CoV-2 variants

Identifiers

PMID40345430
PMCPMC12181171

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.